Illinois General Assembly - Bill Status for SB2353

Synopsis As Introduced
Amends the Illinois Controlled Substances Act. Provides that notwithstanding any other provision of the Act to the contrary, including the scheduling of psilocybin as a Schedule I controlled substance, the Department of Financial and Professional Regulation shall authorize the distribution of, and make publicly available, psilocybin for medical, psychological, and scientific studies, research, and other information relating to the safety and efficacy of psilocybin and other entheogens to treat mental health conditions, including, but not limited to, addiction, depression, anxiety disorders, headache disorders, and end-of-life psychological distress. Provides that the Department of Financial and Professional Regulation shall begin receiving applications for the registration of persons to perform the following: (1) manufacturing psilocybin products; (2) operating a service center; (3) facilitating psilocybin services; and (4) testing psilocybin products.

Actions

Date	Chamber	Action
2/10/2023	Senate	Filed with Secretary by Sen. Rachel Ventura
2/10/2023	Senate	First Reading
2/10/2023	Senate	Referred to Assignments
2/28/2023	Senate	Assigned to Executive
3/10/2023	Senate	Rule 3-9(a) / Re-referred to Assignments

×